AI-Powered Signal Detection in Pharmacovigilance
The AI-Powered Signal Detection in Pharmacovigilance topic, part of the Innovative Health Initiative JU Call 11 under Horizon Europe, aims to revolutionize drug safety by leveraging artificial intelligence. This program supports the development and implementation of advanced AI algorithms and methods for faster and more accurate signal detection and risk prediction in pharmacovigilance, ultimately enhancing patient safety across Europe.
Who is Funded
This section provides an overview of who is generally eligible for funding under the AI-Powered Signal Detection in Pharmacovigilance program. It details the specific types of entities, the geographical scope, and the overarching objectives that define the intended beneficiaries and strategic aims of the program.
What is Funded
This section details the types of projects, thematic areas, and activities eligible for funding, focusing on the specific applications of AI in pharmacovigilance. It clarifies the scope of work supported and the typical developmental stage of the projects.
Type and Scope of Funding
This section provides comprehensive details on the nature and extent of financial support available, including the type of financial instrument used and the maximum funding amount per project.
Conditions and Requirements
This section outlines the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to. It covers application terms, collaboration requirements, budget stipulations, and other important provisions for projects.
Application Procedure
This section guides potential applicants through the various stages of the application procedure for the AI-Powered Signal Detection in Pharmacovigilance program. It covers proposal preparation, submission, required documentation, and explains how applications are evaluated.
Legal Basis
This section outlines the foundational legal documents and regulations that govern the AI-Powered Signal Detection in Pharmacovigilance funding program, ensuring its legitimacy and operational framework.
Similar Programs
Funding Overview
Funding Status:
Open
Maximum Amount:
8,906,000 €
Allocated Budget:
8,906,000 €
Deadline:
09.10.2025, 29.04.2026
Award Channel:
Framework Programme Call
Region:
EU Member States and Horizon Europe Associated Countries (excluding UK and Canada)
Sectors:
Healthcare, Research and Development, Information and Communication Technology, Medical Technology
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
Innovative Health Initiative Joint Undertaking (IHI JU)
Website: